BioDelivery (BDSI) to Restate Certain Financials on BEMA Buprenorphine Revs Recognition
Tweet Send to a Friend
BioDelivery Sciences (Nasdaq: BDSI) filed the following information with the U.S. SEC after markets closed Thursday:
As previously reported ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
As previously reported ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
